Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration

المؤلفون المشاركون

Yamada, Kisaburo
Kimoto, Kenichi
Kubota, Toshiaki
Kono, Hirofumi

المصدر

ISRN Ophthalmology

العدد

المجلد 2011، العدد 2011 (31 ديسمبر/كانون الأول 2011)، ص ص. 1-4، 4ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2011-12-21

دولة النشر

مصر

عدد الصفحات

4

التخصصات الرئيسية

الطب البشري

الملخص EN

Purpose.

To report our experiences in patients with age-related macular degeneration (AMD) treated initially with intravitreal ranibizumab and then switched to bevacizumab.

Methods.

We retrospectively reviewed the records of 7 patients (7 eyes) who were treated with monthly injections of intravitreal ranibizumab and then switched to injections of bevacizumab (every 6 weeks) for six months.

The best-corrected visual acuity measurements (BCVA) and optical coherence tomography (OCT) were performed at the baseline examination and then at each visit.

The Wilcoxon signed-rank test was used for the statistical analysis.

Results.

Following three monthly ranibizumab treatments, there was no significant difference in the BCVA, while the foveal retinal thickness (FRT) significantly decreased (P<0.01).

Switching from ranibizumab to bevacizumab resulted in maintenance (57.2%) of the BCVA and a further decrease in the FRT (P<0.01) after 6 months.

Conclusions.

Switching to intravitreal bevacizumab may be effective in patients who wish to discontinue intravitreal ranibizumab treatment due to the high cost.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Yamada, Kisaburo& Kimoto, Kenichi& Kono, Hirofumi& Kubota, Toshiaki. 2011. Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration. ISRN Ophthalmology،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-507887

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Yamada, Kisaburo…[et al.]. Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration. ISRN Ophthalmology No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-507887

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Yamada, Kisaburo& Kimoto, Kenichi& Kono, Hirofumi& Kubota, Toshiaki. Switching from Intravitreal Ranibizumab to Bevacizumab for Age-Related Macular Degeneration. ISRN Ophthalmology. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-507887

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-507887